- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02245126
The Use of Lignocaine and Bupivacaine Mix in Adult Safe Male Circumcision
The Use of Lignocaine and Bupivacaine Mix in Adult Safe Male Circumcision; Less is More
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The objective of this study therefore was to assess self-reported pain and adverse events when using two different concentrations of lignocaine and bupivacaine mixture while performing routine safe medical circumcision (SMC).
Methods Design This was an observational analytical study.
Setting At an urban high volume SMC site in a resource limited setting, over a 6 weeks period.
Participants Adult males aged18 - 49 years presenting for routine voluntary SMC were recruited for enrollment. All men were offered voluntary HIV counseling and testing before the surgery, received group counseling /health education on HIV prevention, were offered HIV testing, individual counseling where necessary to address questions and to clarify any queries, and free condoms were available. All participants were screened for contraindications to SMC such as active sexual transmitted infections (STI), commonly manifesting as urethral discharge or penile ulcers.
Ethical consideration All participants after they were counselled and provided written informed consent. Ethical approval was obtained from the Makerere College of Health Sciences Ethics and Research Committee.
Lignocaine and Bupivacaine (LiB) mixtures and procedure Lignocaine 2% and bupivacaine 0.5% were procured locally, from suppliers licensed and approved by the national drug authority (NDA), and was within the expiry date. The 4-4-2 mix was 4cc of Lignocaine 2%, 4cc of 0.5% bupivacaine and 2cc of water for injection, all drawn into a 10cc syringe. The 3-3-4 mix was 3cc of Lignocaine 2%, 3cc of bupivacaine 0.5% and 4 cc of water for injection.
We assigned participants to the two groups (each group on alternative weeks). We administered additional local analgesia for those who experienced break-through pain during the procedure. We recorded the mix ratio, the time the procedure commenced and ended using a stop clock, presence of break-through pain during SMC, and pain at 30 and 60 minutes after SMC (post-operative). We encouraged clients to report pain and a visual analogue score (VAS) pain chart was used to estimate pain intensity. Post-operative pain was graded as mild if the VAS score were 0-5, moderate if scores were 6-8 and severe if 9-10. We monitored the clients in the recovery room for additional post-operative pain and oral analgesia were given when and if was needed.
Other adverse events: participants were observed for central nervous system (CNS) toxicity, convulsions, coma and respiratory depression and cardiovascular system (CVS) toxicity Bradycardia pulse rate < 60bpm (beats per minute)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kampala, Uganda, 414
- International hospital Kampala
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- all adult male aged18 and 49 years
Exclusion Criteria:
- severe comorbid states such as sickle cell disease
- uncontrolled diabetes
- hypertension
- active sexually transmitted infections and genital ulcers
- in addition known allergy to lidocaine or bupivacaine
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lignocaine-bupivacaine lower dosage mix
Men who received the 3-3-4 local anaesthetic mix( 3 cc of lignocaine 2% , 3cc of bupivacaine 0.5% and 4cc of water for injection) 3-3-4 mix was administered |
the drug mix included lidocaine, bupivacaine and water for injection
Other Names:
|
Active Comparator: Lignocaine-bupivacaine higher dosage mix
In this group (4-4-2 group) eligible men were receiving an injection of the 4-4-2 local anesthetic mix ( composed of 4cc of parental lignocaine 2%, 4cc of parental bupivacaine 0.5% and 2cc of water for injection).
This mix is given once before commencement of the surgical procedure safe male circumcision.
|
In this group (4-4-2 group) eligible men were receiving an injection of the 4-4-2 local anesthetic mix ( composed of 4cc of parental lignocaine 2%, 4cc of parental bupivacaine 0.5% and 2cc of water for injection).
This mix is given once before commencement of the surgical procedure safe male circumcision.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pain score
Time Frame: immediate post operative period
|
measure at intervals after the procedure is completed
|
immediate post operative period
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Moses Galukande, MD, International Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Postoperative Complications
- Pain
- Neurologic Manifestations
- Pain, Postoperative
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
- Bupivacaine
Other Study ID Numbers
- REC REF 2014-050
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Operative Pain
-
Kaohsiung Medical University Chung-Ho Memorial...Not yet recruitingPostoperative Complications | Chronic Post Operative Pain | Acute Post Operative PainTaiwan
-
MercyOne Des Moines Medical CenterTerminatedPost Operative Pain | Post Operative Nausea and VomitingUnited States
-
University Tunis El ManarCompletedPost-operative Pain | Post-operative AnxietyTunisia
-
E-DA HospitalNot yet recruitingCesarean Section | Post Operative Pain, Acute | Post Operative Pain, ChronicTaiwan
-
University of HaifaRecruiting
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingPost Operative PainSpain
-
Sohag UniversityNot yet recruitingPost Operative Pain
-
Tribhuvan University Teaching Hospital, Institute...Recruiting
-
Beijing Tide Pharmaceutical Co., LtdThe Third Xiangya Hospital of Central South UniversityNot yet recruitingPain, Post-operativeChina
-
Benaroya Research InstituteRecruitingPost Operative PainUnited States
Clinical Trials on 3-3-4 mix
-
Jeffrey A. Cohen, MDJacobus PharmaceuticalTerminatedMuscle WeaknessUnited States
-
Pharma Holdings ASCTC Clinical Trial Consultants ABCompletedNasal Decolonization of Staphylococcus AureusSweden
-
Seoul National University HospitalUnknown
-
Merz Pharmaceuticals GmbHCompletedCorrection of Facial Wrinkles/Folds | Facial Volume EnhancementGermany
-
Wuhan UniversityCompletedBreast Cancer | Modified Radical Mastectomy | Shoulder DysfunctionChina
-
Otto Bock Healthcare Products GmbHCompletedLower Limb Amputation Above Knee (Injury)Austria, Belgium
-
Klinikum der Universität KölnUnknown
-
Tufts UniversityCompletedMild Cognitive ImpairmentUnited States
-
Hospital Departamental de VillavicencioCooperative University of ColombiaRecruiting
-
The University of Tennessee, KnoxvilleRecruiting